Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2012; 18(43): 6302-6307
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6302
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6302
Figure 1 Flow chart of the study.
OME: Omeprazole; CLA: Clarithromycin; AMO: Amoxicillin; POCA: Probiotic pre-treated group; OCAP: Probiotic post-treated group; OCA: Standard therapy group.
Figure 2 Flow diagram showing numbers of patients enrolled and missed for per protocol and intention-to-treat analyses.
ITT: Intention-to-treat; PP:Per-protocol; RUT: Rapid urease test; POCA: Probiotic pre-treated group; OCAP: Probiotic post-treated group; OCA: Standard therapy group.
Figure 3 Helicobacter pylori eradication rates in groups treated with triple therapy, with or without probiotics.
aP < 0.05, bP < 0.01 vs the standard therapy group (OCA group) by Fisher’s exact test. H. pylori: Helicobacter pylori; POCA: Probiotic pre-treated group; OCAP: Probiotic post-treated group; PP: Per protocol; ITT: Intention-to-treat.
-
Citation: Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, Guo CY, Xu P, Gong YF, Li ZS. Adjuvant probiotics improve the eradication effect of triple therapy for
Helicobacter pylori infection. World J Gastroenterol 2012; 18(43): 6302-6307 - URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i43.6302